The benefit of aspirin
in reducing cardiovascular (CV) events or mortality in those patients with
known CV disease (secondary prevention) is well established. However, the benefit of aspirin in those
without CV disease (primary prevention) is less clear. Various organizations have differing opinions
and recommendations regarding who, if anyone, should receive aspirin in this
capacity, and their recommendations are summarized further below. To go straight to the current recommendations, skip down to 'Current Recommendations'.
HughesMedicine - Pharmacotherapy Pearls from the Internal Medicine Clinical Pharmacist
Recommended for you
-
Bleeding risk with anticoagulant and antiplatelet medications is something that we struggle with on a regular basis. Should we fully anti...
-
Let’s start with a patient case. A patient is being treated with methylprednisolone 20 mg IV q6 hours for some inflammatory process and...
-
A 65 year old male is being treated for an infection on his forearm that developed purulent drainage within the last few days. He denies ...
-
The American Geriatrics Society recently published their Alternative Treatments to Selected Medications in reference to the most recent upd...
-
Since it's the time of year again when Lyme disease is a concern for patients in many parts of the United States, I thought it would b...
-
Thrombocytopenia is a notable adverse effect of linezolid. Some of the evidence behind the onset, duration, and the extent of platelet de...
-
A 48 year old male is admitted to the hospital after experiencing a fever and malaise for several days. He states that he has some shortn...
-
A 55 year old business executive is being discharged from the hospital after a brief admission for cellulitis. His only PMH is HTN and o...
-
Let’s start with a patient scenario. A patient presents to the emergency room experiencing a heart failure exacerbation. When entering th...
-
Let’s start with a patient case. Patient is an 80 year old female hospitalized for pneumonia with sepsis who during this admission expe...
